Press Releases

Webcast 2Q FY09 China Medical Technologies, Inc. Earnings Conference Call  (Replay) 11/19/09 at 8:00 a.m. ET

2Q FY09 China Medical Technologies, Inc. Earnings Conference Call Thursday, November 19, 2009 8:00 a.m. ET / 9:00 p.m. CCT  Webcast Presentation Help   Click here for webcast

Receive Email Alerts

Date Title   11/19/09 China Medical Technologies Reports Second Fiscal Quarter Financial Results BEIJING, Nov. 19 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its unaudited financial results for the second fiscal quarter ended September 30, 2009 ("2Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009"). 2Q FY2009 Highlights -- Revenues decreased by 14.4% y...  11/17/09 China Medical Technologies Announces Shareholder Resolution Adopted at its Annual General Meeting Held on November 16, 2009 BEIJING, Nov. 17 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced shareholder resolution adopted at its annual general meeting of shareholders held in Beijing on November 16, 2009. At the annual general meeting, the Company's shareholders approved the China Medical Technologies, Inc. 2009 Equity ...  11/09/09 China Medical Technologies Receives SFDA Approval for its Leukemia BCR/ABL Fusion Gene Detection FISH Probe BEIJING, Nov. 9 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Leukemia BCR/ABL fusion gene detection FISH Probe (the "Leukemia BCR/ABL FISH Probe") from the State Food and Drug Administration of China (the "SFDA"). The Leukemia BCR/ABL FISH Probe ...  11/02/09 China Medical Technologies to Announce Unaudited Financial Results for the Second Fiscal Quarter Ended September 30, 2009 on November 19, 2009 BEIJING, Nov. 2 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will report its unaudited financial results for the second fiscal quarter ended September 30, 2009 ("2Q FY2009") before the U.S. market opens on November 19, 2009. The Company's 2009 fiscal year ends on March 31, 2010. The...  10/28/09 China Medical Technologies to Hold its Annual General Meeting on November 16, 2009 BEIJING, Oct. 28 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company will hold its annual general meeting of shareholders at the Company's office at 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, the People's Republic of China on November 16, 20...  10/21/09 China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China BEIJING, Oct. 21 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will attend the 62nd China International Medical Equipment Fair ("CMEF") from October 28 to October 31, 2009 in Chengdu, China. Exhibition Details Event: 62nd China International Medical Equipment Fair Date: ...  10/19/09 China Medical Technologies Announces the SFDA Approval for its SPR System BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its SPR- based analysis system (the "SPR System") from the State Food and Drug Administration of China (the "SFDA"). The SPR System utilizes Surface Plasmon Resonance ("SPR") technology, a...  09/30/09 China Medical Technologies Files its Annual Report on Form 20-F Containing its Audited Consolidated Financial Statements for the Fiscal Year Ended March 31, 2009 with the SEC BEIJING, Sept. 30 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in- vitro diagnostic products, today announced the filing of its annual report on Form 20-F for the fiscal year ended March 31, 2009 with the U.S. Securities and Exchange Commission (the "SEC"). The annual report, which contains its consolidated financial statements for the fiscal ...  09/30/09 China Medical Technologies Adjusts Conversion Rates of its US$150 Million Convertible Notes and US$276 Million Convertible Notes BEIJING, Sept. 30 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced adjustments to conversion rates of the Company's US$150 million outstanding 3.5% Convertible Senior Subordinated Notes due November 2011 (the "US$150 million Convertible Notes") and the Company's US$276 million outstanding 4.0% Converti...  09/18/09 China Medical Technologies Announces US$30 Million Share Repurchase Program BEIJING, Sept. 18 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that its board of directors (the "Board") approved a share repurchase program on September 17, 2009. The Board has authorized the Company to repurchase up to US$30 million worth of its outstanding American Depositary Shares ("ADSs...  09/01/09 China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results BEIJING, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its unaudited financial results for the first fiscal quarter ended June 30, 2009 ("1Q FY2009"). The Company's 2009 fiscal year ends on March 31, 2010 ("FY2009"). 1Q FY2009 Highlights -- Revenues from continuing operations...  09/01/09 China Medical Technologies Reports FY2008 Fourth Fiscal Quarter and Full Year Unaudited Financial Results BEIJING, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its unaudited financial results for the fourth fiscal quarter ("4Q FY2008") and the full fiscal year ended March 31, 2009 ("FY2008"). 4Q FY2008 Highlights -- Revenues from continuing operations increased by 37.3% year-over-y...  08/20/09 China Medical Technologies to Announce Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year ended March 31, 2009 and the First Fiscal Quarter ended June 30, 2009 on September 1, 2009 BEIJING, Aug. 20 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will report its unaudited financial results for the fourth fiscal quarter ("4Q FY2008") and fiscal year ended March 31, 2009 ("FY2008") and the first fiscal quarter ("1Q FY2009") ended June 30, 2009 before the U.S. market opens o...  08/07/09 China Medical Technologies Announces Change of Independent Auditors BEIJING, Aug. 7 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced the appointment of PricewaterhouseCoopers ("PwC") as the Company's independent registered public accounting firm. PwC replaces the Company's previous independent auditors, KPMG. The appointment of PwC in replacement of KPMG has been...  07/30/09 China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20 BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced the substantial completion of an independent internal investigation and the expected reporting in late August 2009 of unaudited financial results for the quarter and fiscal year ended March 31, 2009 and the quarter ended June 30, 2009. ...  06/19/09 China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009 BEIJING, June 19, 2009 /PRNewswire-Asia-FirstCall via COMTEX/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced selected unaudited preliminary financial results for the fourth fiscal quarter (''4Q FY2008'') and the full year of the fiscal year ended March 31, 2009 (''FY2008''). The Company's 2008 fiscal year ends on March 31, 2009. ...  04/27/09 China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe BEIJING, April 27 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Bladder Cancer FISH Probe (the "Probe") from the State Food and Drug Administration (the "SFDA") in the People's Republic of China. The Probe is an advanced molecular diagnostic test ...  03/25/09 China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System BEIJING, March 25 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company received quality testing certificate (the ''Certificate'') for its SPR-based Analysis System (the ''SPR System'') from one of the State Food and Drug Administration (the ''SFDA'') Quality Supervision and Testing Centr...  03/06/09 China Medical Technologies Senior Management Purchased Company Shares BEIJING, March 6 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that each of Mr. Xiaodong Wu, the Company's Chairman and Chief Executive Officer, Mr. Sam Tsang, the Company's Chief Financial Officer and Dr. Zhong Chen, the Company's Chief Technology Officer, purchased the Company's American Depositar...  03/02/09 China Medical Technologies Reports Third Fiscal Quarter Financial Results Click here to download PDF version BEIJING, March 2, 2009 /PRNewswire-Asia-FirstCall via COMTEX/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its unaudited financial results for the third fiscal quarter ended December 31, 2008 ("3Q FY2008"). The Company's 2008 fiscal year ends on March 31, 2009 ("FY2008"). 3Q FY2008 H...  02/10/09 China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009 BEIJING, Feb. 10 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will report its unaudited financial results for the third fiscal quarter ended December 31, 2008 (''3Q FY2008'') before the U.S. market opens on March 2, 2009. The Company's fiscal year ends on March 31, 2009 (''FY2008''). ...  01/22/09 China Medical Technologies Announces the Receipt of SFDA Approval for Two of its FISH Probes and the Approval for the Hi-Tech Enterprise Status for its PRC Subsidiaries BEIJING, Jan. 22 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Prenatal FISH Probe and Cervical Cancer FISH Probe from the State Food and Drug Administration (the "SFDA") in the People's Republic of China (the "PRC"). The Prenatal FISH Probe is a ...